Handelsavisen
prelaunch
Companies Financials 2628.HK
26
2628.HK HKEX Life & Health Insurance

China Life Insurance Co Ltd

HK$31,04
Open in Charts → Attach watcher ⌖
HKD
Set alert
LatestChina Life launches $737m semiconductor fund as Beijing pushes for patient capital
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
231,0B HKD
P/E
1,4x
EV / Rev
Div yield
3,39 %
Op margin
ROE
Net margin
Debt / equity
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

China Life Insurance Co Ltd provides life and health insurance products and services in China and internationally.

Business. China Life Insurance Co Ltd (2628.HK) is a life and health insurance company headquartered in China. The firm operates within the Financials sector, specifically focusing on the Life & Health Insurance industry. It is primarily listed on the Hong Kong Stock Exchange. Specific details regarding operating segments and geographic revenue mix are not provided.

Classification92 %
SectorFinancials
Business sectorInsurance
IndustryLife & Health Insurance
Generated · model-assisted
Sell-side consensus
BUY17 analysts
16 buy1 hold0 sell
Avg 12m price target33,47

Analyst recommendations

17 analysts · consensus Buy
Buy16
Hold1
Sell0
12-month price target
33,47
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
1,4x
P/E
Analysts
Buy
17 analysts · indicative
Ownership
not yet wired
Profitability
not yet wired
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

1
  • MARKETSChina Life launches $737m semiconductor fund as Beijing pushes for patient capital2026-07-12
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials · THIS SECTOR−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 2628.HK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    Briefing · model-assisted

    China Life Insurance Co Ltd (2628.HK) is currently undergoing its first analysis, meaning there is no prior basis for computing material changes or deltas in its operational or financial metrics. Consequently, no specific shifts in performance, strategy, or market position can be asserted based on the available data. The company’s current profile indicates a lean executive structure with only one officer on record, alongside a modest level of analyst coverage from nine analysts. It maintains membership in one index, though no top holders are currently identified in the dataset. Recent monitoring of cross-source signals reveals a period of minimal activity, with zero dispatches recorded daily from June 24 through July 11, 2026. A single dispatch was noted on July 12, 2026, but no sentiment data was attached to this event, and activity returned to zero in the subsequent days. Given the absence of material changes, watcher signals, or saga developments, the significance of this snapshot lies in establishing a baseline for future comparison. Investors and analysts should note that the current data reflects a static state with no reported volatility or notable corporate actions during the observed period.

    Signals & dispatch

    peak dispatch · 2026-07-12

    Composite-score breakdown

    Synthesis

    Business

    China Life Insurance Co Ltd (2628.HK) is a life and health insurance company headquartered in China. The firm operates within the Financials sector, specifically focusing on the Life & Health Insurance industry. It is primarily listed on the Hong Kong Stock Exchange. Specific details regarding operating segments and geographic revenue mix are not provided.

    Classification92 %
    SectorFinancials
    Business sectorInsurance
    IndustryLife & Health Insurance
    AI synthesis
    GENERATED

    China Life Insurance Co Ltd has a market capitalization of 218.92 billion CNY, with a market price of 29.42 CNY per share. The company has 7.44 billion shares outstanding, with no dilution observed between basic and diluted shares. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.

    Profitability and returns data are not available in the current snapshot, and no industry_config preferred metrics are provided for comparison. Analysts have assigned a mean price target of 33.47 CNY and a median price target of 33.05 CNY, indicating a generally positive outlook.

    Segment and geographic exposure details are not disclosed in the available data. The company operates primarily in China and internationally, but specific revenue concentration by segment or region is not provided.

    Growth trajectory is not quantified in the current data, but analyst estimates suggest a positive outlook with a mean recommendation of 1.71, indicating a strong buy to hold range.

    Risk factors include the inability to assess liquidity risk due to missing balance-sheet inputs and no going-concern language in source documents. Dilution risk is currently low, with no near-term pressure expected.

    Recent events and filings are not detailed in the available data. Analysts have issued 6 strong-buy, 10 buy, and 1 hold recommendations, reflecting a generally optimistic sentiment.

    China Life Insurance Co Ltd (2628.HK) is currently undergoing its first analysis, meaning there is no prior basis for computing material changes or deltas in its operational or financial metrics. Consequently, no specific shifts in performance, strategy, or market position can be asserted based on the available data. The company’s current profile indicates a lean executive structure with only one officer on record, alongside a modest level of analyst coverage from nine analysts. It maintains membership in one index, though no top holders are currently identified in the dataset. Recent monitoring of cross-source signals reveals a period of minimal activity, with zero dispatches recorded daily from June 24 through July 11, 2026. A single dispatch was noted on July 12, 2026, but no sentiment data was attached to this event, and activity returned to zero in the subsequent days. Given the absence of material changes, watcher signals, or saga developments, the significance of this snapshot lies in establishing a baseline for future comparison. Investors and analysts should note that the current data reflects a static state with no reported volatility or notable corporate actions during the observed period.

    Key takeaways
    • Analysts have a generally positive outlook, with a mean price target of 33.47 CNY and a median price target of 33.05 CNY.
    • The company has no dilution between basic and diluted shares, indicating stable capital structure.
    • Liquidity risk could not be assessed due to missing balance-sheet inputs and no going-concern language in source documents.
    • Analysts have issued 6 strong-buy, 10 buy, and 1 hold recommendations, reflecting a generally optimistic sentiment.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Annual
    ANNUALFiled 2026-03-25
    FY 2026 · Full-year highlights

    Operating income +55,6% YoY; Net income +44,1% YoY.

    Revenue
    Operating income¥185.79B+55,6 % YoY
    Net income¥154.08B+44,1 % YoY
    Free cash flow¥141.19B+48,0 % YoY
    EPS
    Operating cash flow¥459.93B+21,4 % YoY
    Financials
    Income statement
    Revenue
    Gross profit
    Operating income¥185.79B
    Net income¥154.08B
    Balance sheet
    Total assets¥7.59T
    Total liabilities¥7.00T
    Total equity¥595.21B
    Cash & equivalents¥142.37B
    Long-term debt¥35.25B
    Cash flow
    Operating cash flow¥459.93B
    CapEx
    Free cash flow¥141.19B
    SBC
    Highlights
    • Operating income +55,6% YoY
    • Net income +44,1% YoY
    • Free cash flow +48,0% YoY

    Valuation FY

    Market price
    HK$31,04
    Market cap
    HK$218.92B
    Enterprise value
    P/E
    1.4x
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    Net cash
    Current ratio
    Debt / equity
    ROA
    ROE
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    4,22
    Predicted surprise
    -0,00
    Beat probability
    45 %
    Analysts
    17
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-01 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate4,22
    Revenueno estimateno estimate232,8B CNY
    Operating incomeno estimateno estimate187,4B CNY
    Full-year consensus mean (period as reported by source) · consensus in CNY. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution17 analysts
    Strong buy6
    Buy10
    Hold1
    Sell0
    Strong sell0
    12-month price targetHK$33,47 · Median HK$33,05
    Low HK$14,00High HK$44,50
    Operating income · consensus187,4B CNY
    EPS surprise
    +29,0 %
    reported vs consensus · beat
    Revenue surprise
    −8,0 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    LowHK$14,00
    MeanHK$33,47
    MedianHK$33,05
    HighHK$44,50
    SpotHK$31,04
    +7.8 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskUnknown

    Benchmarks vs cohort

    No cohort benchmark data available for this issuer yet.

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • China Life Insurance Co Ltd Market data — financials · 2026-05-26
    • China Life Insurance Co Ltd Market data — analyst estimates · 2026-05-26

    Ownership & reference

    Leadership

    • Tao BaiExecutive Chairman of the Board

    Insider activity

    — missing data

    Short positioning

    — missing data
    Index membership
    Hang Seng

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    2628.HKCanonical
    HKEX · HKD

    Intel & risk

    PredictorBeat prob45 %Surprise-0,00Full forecast →
    peak dispatch · 2026-07-12
    OSINT findings
    Dilution riskLow
    Liquidity riskUnknown

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-03-25 14:48 UTCEARNINGSAnnual results — FY 2026 Net CNY 154.08B
    2025-03-26 15:21 UTCEARNINGSAnnual results — FY 2025 Net CNY 106.94B
    2024-03-27 16:30 UTCEARNINGSAnnual results — FY 2024 Net CNY 46.18B
    2023-03-29 16:28 UTCEARNINGSAnnual results — FY 2023 Net CNY 66.68B
    2022-03-25 01:40 UTCEARNINGSAnnual results — FY 2022 Net CNY 50.77B
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage